Vaxcell-Bio Therapeutics Statistics

Total Valuation

KOSDAQ:323990 has a market cap or net worth of KRW 191.99 billion. The enterprise value is 158.21 billion.

Market Cap	191.99B
Enterprise Value	158.21B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:323990 has 22.99 million shares outstanding. The number of shares has increased by 17.03% in one year.

Current Share Class	n/a
Shares Outstanding	22.99M
Shares Change (YoY)	+17.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.70%
Owned by Institutions (%)	4.65%
Float	19.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	100.89
PB Ratio	2.66
P/TBV Ratio	2.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.89
EV / Sales	83.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.34

Financial Position

The company has a current ratio of 13.87, with a Debt / Equity ratio of 0.03.

Current Ratio	13.87
Quick Ratio	13.45
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-66.99

Financial Efficiency

Return on equity (ROE) is -13.66% and return on invested capital (ROIC) is -11.92%.

Return on Equity (ROE)	-13.66%
Return on Assets (ROA)	-11.64%
Return on Invested Capital (ROIC)	-11.92%
Return on Capital Employed (ROCE)	-20.35%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	9.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.77% in the last 52 weeks. The beta is 3.38, so KOSDAQ:323990's price volatility has been higher than the market average.

Beta (5Y)	3.38
52-Week Price Change	-60.77%
50-Day Moving Average	9,515.20
200-Day Moving Average	12,778.10
Relative Strength Index (RSI)	27.84
Average Volume (20 Days)	103,585

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:323990 had revenue of KRW 1.90 billion and -10.62 billion in losses. Loss per share was -463.00.

Revenue	1.90B
Gross Profit	361.57M
Operating Income	-15.08B
Pretax Income	-10.62B
Net Income	-10.62B
EBITDA	-13.62B
EBIT	-15.08B
Loss Per Share	-463.00

Full Income Statement

Balance Sheet

The company has 36.05 billion in cash and 2.27 billion in debt, giving a net cash position of 33.79 billion or 1,469.42 per share.

Cash & Cash Equivalents	36.05B
Total Debt	2.27B
Net Cash	33.79B
Net Cash Per Share	1,469.42
Equity (Book Value)	71.99B
Book Value Per Share	3,140.35
Working Capital	36.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.70 billion and capital expenditures -2.12 billion, giving a free cash flow of -12.82 billion.

Operating Cash Flow	-10.70B
Capital Expenditures	-2.12B
Free Cash Flow	-12.82B
FCF Per Share	-557.71

Full Cash Flow Statement

Margins

Gross Margin	19.04%
Operating Margin	-794.20%
Pretax Margin	-559.45%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:323990 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.03%
Shareholder Yield	-17.03%
Earnings Yield	-5.53%
FCF Yield	-6.68%

Stock Splits

The last stock split was on November 10, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Nov 10, 2023
Split Type	Forward
Split Ratio	1.2

Scores

KOSDAQ:323990 has an Altman Z-Score of 44.44.

Altman Z-Score	44.44
Piotroski F-Score	n/a